MCH ADVISORY EQUITY RESEARCH
Institutional research — not investment advice ← Library
IEX HOLD REF $221 PW TARGET $216 (-2% vs spot · 12m PWEV) -2% Single-name research · 8 July 2026
Equity ResearchIndustrials · Industrial Machinery & Supplies & Components
IEX

IDEX Corporation (IEX)

HOLD. 12-month probability-weighted target $216 (-2% vs spot). P/E Multiple explains 60% of Monte Carlo outcome variance.

Verdict
HOLD
Triangulated fair value $198 (-10% vs spot · triangulated FV)
Reference
$221
Close · 8 July 2026
PW Target
$216 (-2% vs spot · 12m PWEV) -2%
Probability-weighted
Horizon
12 mo
MCH Advisory
$198 (-10% vs spot · triangulated FV)
Fair value
$216 (-2% vs spot · 12m PWEV)
Scenario PWEV
26.3x
Forward P/E
$16B
Market cap
$155–$230
52-week range
Contents

Rating: HOLD

HOLD (5-tier) · mature cash generator · conviction: medium

Metric Value
Current Price $221
Triangulated Fair Value $198 (-10% vs spot · triangulated FV)
12-mo Scenario PWEV $216 (-2% vs spot · 12m PWEV)
Forward P/E 26.3x
Market Cap $16B
52-Week Range $155–$230

EPS basis for the forward P/E and all scenario multiples: consensus forward EPS (broker-adjusted, non-GAAP).


Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-27. Each chart below sits with the part of the thesis it evidences.

General research for a skeptical institutional reader. Not personalised investment advice; no position sizing or trade instructions. Figures as of the analysis date; verify before acting.

Investment Committee Summary

Rating HOLD · HOLD (5-tier)
Classification · conviction mature cash generator · medium
Triangulated fair value $198 (-10% vs spot · triangulated FV)
12-mo scenario PWEV $216 (-2% vs spot · 12m PWEV)
Next catalyst 2026-07-29 — Quarterly earnings
Primary thesis-break Organic revenue growth (constant currency, ex-M&A) < 0.01 (2 consecutive prints)

📎 Download the full model (Excel) — DCF line items, scenarios, sensitivity, assumptions, and extended fundamentals.

Rating Bridge

Rating = HOLD because:

  • Probability-weighted scenario value implies -2% vs spot
  • Monte Carlo median implies -8% vs spot
  • DCF fair value implies -20% vs spot — but this is terminal-value sensitive (exit-multiple $176 vs Gordon $127, 28% apart), so it carries less weight
  • Bear case (Structural — Portfolio / End-Market Disruption) downside is -57% vs spot
  • Net: reward/risk of 0.2× is not asymmetric enough for a Buy and not impaired enough for a Sell — hence Hold.

Investment Thesis

At $226.95 (27 June 2026) IEX trades on roughly 27x forward earnings, a premium to the diversified-industrial peer median near 26x. Spot embeds the market's belief that IDEX remains a high-return, cash-generative compounder: low-single-digit organic volume, a low-twenties adjusted operating margin, and steady bolt-on M&A funded from an above-100% cash-conversion base. Our engine broadly agrees on the business quality but not on the entry price. The base scenario computes to roughly $226 against a $226.95 spot, and the probability-weighted target of $227 sits within a point of it; the peer and DCF anchors ($176 base, $216-$221 implied) pull below the market multiple. The rating is HOLD because the weighted fair value offers no margin of safety and the P/E multiple, not earnings, drives most of the variance (about 60% of Monte Carlo dispersion). The single most damaging risk is a short-cycle destock: manufacturing PMI below 50 with a channel inventory reset would take organic growth negative, compress decremental margins, and de-rate a premium multiple simultaneously.

The dashboard below is the whole argument on one page: spot ($221) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Integrated dashboard. The five valuation anchors bracket the $221 spot from <img src=
Integrated dashboard. The five valuation anchors bracket the $221 spot from $176 to $221 — stretched — spot sits above the skeptical blend.

Anti-Thesis (The Real Bear Case)

The highest-probability bear is structural, not merely cyclical, at a 20% weight. IDEX is a roll-up of small, high-margin fluidics and dosing niches, and the premium multiple assumes each niche keeps its pricing power indefinitely. If one core platform loses relevance to a substitute technology, or an acquired business is overpaid for and later impaired, revenue falls while fixed cost is absorbed on a smaller base and the operating margin de-rates toward the mid-teens. The multiple then compresses from 27x toward a deep-cyclical 18x at the same time, because the market re-prices the compounder narrative rather than just the current cycle. Earnings and the multiple fall together; the structural target sits below the 52-week low of $155.45 by construction, and cash conversion weakens as the M&A engine stalls.

Key Debate

P/E Multiple explains 60% of Monte Carlo outcome variance — i.e. value is set by the multiple the market will pay, a rate/sentiment regime bet as much as an earnings bet.

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q1): management +0.41 vs analyst floor +0.00 → delta +0.41 (n=33 mgmt / 25 Q&A; 54th pctile across the S&P book, z +0.1).

Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.

Quarter Mgmt Analyst Delta
2026Q1 +0.41 +0.00 +0.41
2025Q4 +0.36 +0.01 +0.35
2025Q3 +0.44 +0.33 +0.12
2025Q2 +0.32 +0.14 +0.18

News (last 365d, 660 articles): avg ticker sentiment +0.22 (bullish 41% / bearish 3%)

Scenario Analysis

The tree runs from a structural 'Structural — Portfolio / End-Market Disruption' downside ($95) to a 'Bull — Re-Rate' bull case ($384); the probability-weighted blend (PWEV $216) is -2% versus spot.

Scenario Probability Target Return vs spot
Structural — Portfolio / End-Market Disruption 20% $95 -57%
Industrial-PMI Recession 17% $161 -27%
Base — Organic Growth + Margin 35% $226 +2%
Growth — Productivity / Reshoring / Automation 20% $302 +37%
Bull — Re-Rate 8% $384 +74%
Probability-Weighted (PWEV) $216 -2%

Scenario rationale — what each probability buys (the driver path behind every target):

  • Structural — Portfolio / End-Market Disruption (20%, $95). Structural impairment — portfolio / end-market disruption: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 99.91; probability: 0.2.
  • Industrial-PMI Recession (17%, $161). Cyclical downturn — short-cycle industrial demand (PMI) + pricing + portfolio/automation mix weakens for 1–2 years before normalising. Drivers — implied_target: 169.67; probability: 0.17.
  • Base — Organic Growth + Margin (35%, $226). Mid-cycle — normalised short-cycle industrial demand (PMI) + pricing + portfolio/automation mix; disciplined capital allocation; steady returns. Drivers — implied_target: 235.65; probability: 0.35.
  • Growth — Productivity / Reshoring / Automation (20%, $302). Upside — productivity + reshoring + automation lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 318.13; probability: 0.2.
  • Bull — Re-Rate (8%, $384). Upside tail — sustained tight conditions or a structural re-rate on productivity + reshoring + automation. Drivers — implied_target: 401.78; probability: 0.08.
Five-scenario tree. Probability-weighted targets around the $221 spot; PWEV $216 (-2% vs spot · 12m). the payoff shows modest negative expectancy — downside mass dominates (range $95–$384)
Five-scenario tree. Probability-weighted targets around the $221 spot; PWEV $216 (-2% vs spot · 12m). the payoff shows modest negative expectancy — downside mass dominates (range $95–$384)

Valuation Triangulation

Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.

Method Basis Fair Value vs Spot
Monte Carlo median (Student-t + regime) multiple $204 -8%
Peer P/E re-rate multiple $221 +0%
Peer EV/Revenue re-rate multiple $216 -2%
Scenario PWEV multiple $216 -2%
DCF (5-year + terminal) cash flow + terminal × $176 -20%
Triangulated (weighted) $198 -10%

Peer EV/Revenue re-rate — 0% weight: it duplicates the peer-multiple information already carried by the Peer P/E anchor while ignoring margin mix; weighting both would double-count the peer view. Shown as a cross-check.

Monte Carlo — the distribution, not a point

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $204 and 42% of paths finish above spot. The variance decomposition shows the p/e multiple is the dominant swing factor (60% of variance). Value is a multiple bet: fundamentals move the answer far less than the rating does.

Monte Carlo distribution. Median $204; P(price > current) 42%. P10–P90: <img src=
Monte Carlo distribution. Median $204; P(price > current) 42%. P10–P90: $113–$336.

DCF — the cash-flow anchor

Independent of the market multiple: a 5-year path, WACC 9.0%, 23x terminal FCF multiple → $176. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.

Independent DCF. WACC 9.0%, 23x terminal → <img src=
Independent DCF. WACC 9.0%, 23x terminal → $176.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median forward multiple (P/E 26.325x) implies $221. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.

Cross-sectional peer benchmarking. Peer-median fwd P/E 26.325x → $221; EV/Rev re-rate → $216.
Cross-sectional peer benchmarking. Peer-median fwd P/E 26.325x → $221; EV/Rev re-rate → $216.

Across all anchors the spread is 21% of the median — moderate (healthy method disagreement — read the blend with care).

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Segment Revenue Mix Growth Op margin EBIT Multiple Capex % Tag
Diversified Industrial Machinery $3.5B 100% 5% 21% $0.7B 27x 3% ESTIMATE
EBIT = segment revenue × operating margin (segment EBITDA not shown — per-segment D&A is not separately disclosed).

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Dimension Assessment
driver short-cycle industrial demand (PMI) + pricing + portfolio/automation mix
net_debt_or_cash_b -1.31

Capital intensity & shareholder returns (ESTIMATE)

Dimension Assessment
capex_pct_revenue 0.03
div_yield 0.0096

Structural risk vs optionality (INFERENCE)

Dimension Assessment
downside portfolio / end-market disruption
upside productivity + reshoring + automation

Industry Context — Ind Machinery

This name sits in the Ind Machinery as a diversified_industrials. short-cycle industrial demand (PMI) + pricing + portfolio/automation mix Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.

Value chain: CAT (heavy_machinery) · DE (heavy_machinery) · HON (diversified_industrials) · PH (diversified_industrials) · CMI (heavy_machinery) · MMM (diversified_industrials) · ITW (diversified_industrials) · GWW (diversified_industrials) · PCAR (heavy_machinery) · WAB (heavy_machinery) · IR (diversified_industrials) · DOV (diversified_industrials) · OTIS (diversified_industrials) · HUBB (diversified_industrials) · XYL (diversified_industrials) · SNA (diversified_industrials) · FTV (diversified_industrials) · NDSN (diversified_industrials) · IEX (diversified_industrials) · SWK (diversified_industrials) · PNR (diversified_industrials)

Shared state Capex path House view This name implies
Industrial-PMI Recession / Inventory Reset 37% 37%
Mid-Cycle — Volumes + Pricing 35% 35%
Upcycle — Capex / Reshoring / Infra 28% 28%

Mapping note: name-level 'Structural — Portfolio / End-Market Disruption' (20%) + 'Industrial-PMI Recession' (17%) map to cluster Industrial-PMI Recession / Inventory Reset (37%); name-level 'Growth — Productivity / Reshoring / Automation' (20%) + 'Bull — Re-Rate' (8%) map to cluster Upcycle — Capex / Reshoring / Infra (28%) — the cluster row is the SUM of the mapped scenario probabilities, not a different estimate.

On the cluster's key downside — Industrial-PMI Recession / Inventory Reset () — this name implies 37% vs the cluster house view of 37% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.

Structure: Shared State — The ind_machinery cycle is the shared macro driver. Driver — industrial capex + PMI + construction/ag/heavy-truck demand + reshoring Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).

Model Appendix

DCF — line items

Year Revenue Op income − Capex + D&A FCF PV(FCF)
FY+1 $4B $1B $0B $0B $1B $1B
FY+2 $4B $1B $0B $0B $1B $1B
FY+3 $4B $1B $0B $0B $1B $1B
FY+4 $4B $1B $0B $0B $1B $1B
FY+5 $4B $1B $0B $0B $1B $1B
Terminal $1B × 23x $12B

FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 3% of revenue, weighted from the segments) — not a single conversion fudge.

WACC 9.0% · Σ PV(FCF) $3B + PV(terminal) $12B = EV $14B; + net cash → equity $13B ÷ diluted shares 0.07B = $176/share (exit-multiple terminal).

  • Gordon (perpetuity-growth) terminal at 2.5% → $127/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
  • Incremental ROIC on the forecast capex ≈ 41% vs WACC 9% → above WACC — the build is value-creative.

Peer set

Peer EV/Rev Fwd P/E Growth Op margin
PH 6.38x 29.07x 5% 22%
ITW 5.31x 23.31x 5% 26%
GWW 3.563x 30.03x 5% 17%
IR 4.567x 23.58x 5% 17%
Median 4.9384999999999994x 26.325x

Peer-median fwd P/E → $221; EV/Rev → $216.

Weighted fair-value math

Anchor Value Weight Contribution
DCF $176 41% $73
Scenario PWEV $216 29% $64
Monte Carlo median $204 18% $36
Peer P/E $221 12% $26
Triangulated 100% $198

Sensitivity

DCF/share — WACC × terminal multiple

WACC \ Term× 16.1x 19.6x 23.0x 26.4x 29.9x
7% $142 $168 $194 $219 $245
8% $136 $161 $185 $209 $234
9% $129 $153 $176 $200 $224
10% $124 $146 $168 $191 $213
11% $118 $140 $161 $182 $204

DCF/share — revenue CAGR Δ × op-margin Δ

CAGRΔ \ MgnΔ -3.0pp -1.5pp +0.0pp +1.5pp +3.0pp
-3.0pp $129 $141 $152 $163 $174
-1.5pp $140 $152 $164 $176 $188
+0.0pp $151 $164 $176 $189 $202
+1.5pp $162 $176 $190 $204 $217
+3.0pp $175 $189 $204 $219 $233

Tornado — DCF/share swing by driver (widest first)

Driver Low High Swing
Revenue CAGR ±3pp $152 $204 $52
Op margin ±3pp $151 $202 $52
Terminal × ±15% $153 $200 $47
WACC ±1pp $168 $185 $16
Capex intensity ±15% $174 $179 $6

Company lever — SoP/share vs Diversified Industrial Machinery multiple (AI re-rating) (base 27x)

Multiple 18.9x 22.9x 27.0x 31.0x 35.1x
SoP/share $876 $1,065 $1,259 $1,449 $1,642

Consensus & Market Expectations

Reference Value
Street target (mean) $238 (+8% vs spot · street)
House target $227 (-4.7% vs street)
Sell-side coverage 15 analysts (SB 1 / B 7 / H 7 / S 0 / SS 0; net score 0.3)
Consensus FY EPS $9.23; house below (-8.9%)
Consensus FY revenue $3.8B; house in-line (-2.6%)

_Consensus figures: Alpha Vantage sell-side aggregates. Where the house view sits materially above or below the street, the divergence is itself a datum — see the thesis.

Balance Sheet & Liquidity

Metric Value
Net debt $1.3B — modestly levered
Net debt / EBITDA 1.33x
Interest coverage (EBIT / interest) 10.9x
Current ratio 2.86x
Lease obligations $0.0B
Cash & ST investments $0.6B

Balance-sheet data as of 2025-12-31 (Alpha Vantage).

Capital Allocation

Metric Value
Free cash flow $0.6B
Buybacks / dividends $0.2B / $0.2B
Total shareholder yield 2.8%
Payout as % of FCF 74.7%
Reinvestment (capex / OCF) 9.4%
SBC as % of FCF 4.4%
Allocation stance returns-heavy

Free-Cash-Flow Quality

Metric Value
FCF margin 17.6%
FCF conversion (FCF / net income) 127.7%
FCF yield 3.8%
Capex intensity (capex / revenue) 1.8%
FCF − SBC (diagnostic) $0.6B
Capex split (maint / growth) 70% / 30% — Capital-light industrial compounder (>100% cash conversion); capex is maintenance-heavy tooling and facilities, with a growth slice for capacity and new-product lines. Growth is funded via M&A, not organic capex.

Accounting quality: SBC 0.8% of revenue; cash conversion (OCF/NI) 141% — cash-backed.

Catalyst Calendar

  • 2026-07-29 (~21d) — Quarterly earnings — est. EPS $2.11 (AV EARNINGS_CALENDAR)
  • 2026-10-25 (~109d) — New-product / platform launch in health & science or fire & safety segment (authored)
  • 2026-11-12 (~127d) — Investor/analyst day or updated capital-allocation / M&A framework (authored)
  • 2027-02-15 (~222d) — Reshoring / automation-demand end-market inflection (industrial PMI recovery) (authored)

Forecast Track Record

  • EPS surprise: beat 100.0% of the last 8 quarters; average surprise +4.3%.

Competitive Moat

Narrow moat. IDEX's moat is a portfolio of niche, mission-critical fluidics/dispensing components with high engineering specification lock-in and pricing power, but no single dominant franchise, so the moat is narrow-to-solid rather than wide. FALSIFIABLE: if organic growth stalls below GDP with flat-to-down margins for two years (no reshoring/automation lift), the ~27x forward multiple exceeds the diversified-industrial ~26x peer median without justification and should compress toward or below it.

Moat sources:

  • Spec-in / designed-in position on mission-critical fluidics and precision components (switching costs, FACT/INFERENCE)
  • Niche-market leadership across many small, hard-to-disrupt end-markets (diversification, FACT)
  • Pricing power and >100% cash conversion funding disciplined bolt-on M&A (FACT)
  • No single franchise dominant enough to constitute a wide moat (INFERENCE)
Issue Probability Valuation sensitivity Horizon
Diversified industrial with light direct regulatory exposure; principal exposure is tariff/trade-policy on component sourcing low (~20%) low - tariff pass-through mostly recoverable, <3% of FV 12-24m

Probabilities and sensitivities are analyst estimates, not market-implied.

Scenario Macro & Key Risks

Scenario Macro assumption Key risk
Structural — Portfolio / End-Market Disruption A structural technology shift or de-specification disrupts one or more core fluidics end-markets, permanently lowering the organic-growth and margin base. Loss of designed-in positions erodes pricing power across the niche portfolio.
Industrial-PMI Recession A global manufacturing/PMI contraction cuts industrial and life-science instrumentation demand for 1-2 years. Short-cycle order declines de-operating-leverage margins before cost actions catch up.
Base — Organic Growth + Margin Low-single-digit organic volume with low-twenties adjusted margin and steady bolt-on M&A on normal industrial conditions. The premium-to-peer multiple assumes M&A compounding that a soft capital-allocation year interrupts.
Growth — Productivity / Reshoring / Automation Reshoring, automation and life-science capex lift IDEX's precision-component demand above trend. Reshoring/automation demand is capex-cyclical and can reverse quickly.
Bull — Re-Rate Sustained above-trend organic growth plus accretive M&A re-rate IEX as a premium quality-compounder. The re-rate leans on a rich starting multiple with little organic-growth cushion.

What the Market Is Pricing In

At the current price, the market pays 24.0× forward EPS, vs the house DCF terminal 23.0×, and a peer median 26.325×. The house DCF sits 20% below spot, so the market is pricing in more than the house case — roughly 2.1pp of revenue CAGR.

Variant perception: the house view is below-consensus, and the thesis is primarily event-driven.

Metric Consensus House Importance
Revenue 3.8 3.7 High
EPS 9.2 8.4 Medium
Target price 238.3 227.1 Medium

Peer Quality & Weighting

Peer Fwd P/E Growth Op margin Quality Weight cap
PH 29.07× 5% 22% direct 100%
ITW 23.31× 5% 26% direct 100%
GWW 30.03× 5% 17% direct 100%
IR 23.58× 5% 17% direct 100%

Quality-weighted forward P/E: 26.5× (simple median 26.325×). Direct peers count 100%, segment 50%, broad 25%.

Historical-range cross-check: 52-week range $155–$230, centre $189 (-14% vs spot); spot sits at the 88th percentile of the range. Low-weight mean-reversion cross-check, not a fundamental anchor.

Risk / Reward & Margin of Safety

Metric Value
Upside to triangulated FV $198 (-10% vs spot · triangulated FV)
Downside to bear case (Structural — Portfolio / End-Market Disruption) $95 (-57% vs spot · bear scenario)
Reward/risk ratio 0.2×
Margin of safety (FV vs spot) -11%
P(price > spot) — Monte Carlo 42%

Reward/risk compares triangulated upside against the probability-weighted bear target, not the extreme tail. Bull case (Bull — Re-Rate): $384.

Assumption Register

Assumption Value Used in Source
WACC 9.0% DCF discount rate estimate (CAPM)
Terminal multiple 23× DCF exit value estimate (peer-anchored)
Terminal growth 2.5% DCF Gordon terminal estimate
SBC dilution 0.0%/yr PWEV, MC, DCF (charged once) estimate (from SBC/rev)
EPS basis consensus forward EPS (broker-adjusted, non-GAAP) all forward P/E & scenario multiples definition

Sensitivity-ranked drivers (widest fair-value swing first): Revenue CAGR ±3pp (52.0); Op margin ±3pp (52.0); Terminal × ±15% (47.0); WACC ±1pp (16.0); Capex intensity ±15% (6.0).

Inputs, Sources & Confidence

Every load-bearing input, labelled by type and confidence. (reported fact · company guidance · consensus estimate · market data · house estimate · inference.)

Input Value Type Source Confidence Used in
Revenue TTM $3.5B reported fact 10-K/10-Q via AV High Forecast base, EV/Rev
FY+1 guided revenue $3.7B company guidance Company guidance Medium Forecast, SoP
Consensus FY EPS $9.2301 consensus estimate Sell-side consensus via AV Medium Variant perception
Diluted shares 0.074B reported fact 10-K via AV High Market cap, per-share
Net debt / cash $1.269B reported fact Balance sheet via AV High EV, DCF equity bridge
WACC 9.0% house estimate CAPM (beta/rf) Medium DCF discount rate
Terminal multiple 23× house estimate Peer/historical range Medium DCF exit value
Terminal growth 2.5% house estimate Long-run GDP+ Medium DCF Gordon terminal

Source Log

Source Type Date Used for Reference
Alpha Vantage — GLOBAL_QUOTE / OVERVIEW market data 2026-07-08 Price, market cap, EV, 52-week range, forward P/E Alpha Vantage 2026-06-27
Company income statement (10-K / 10-Q) via Alpha Vantage reported fact 2026-07-08 Revenue, gross/operating margin, EBIT, interest expense INCOME_STATEMENT / latest annual
Company balance sheet (10-K / 10-Q) via Alpha Vantage reported fact 2026-07-08 Cash, debt, net debt, leases, equity, coverage BALANCE_SHEET / latest annual
Company cash-flow statement (10-K / 10-Q) via Alpha Vantage reported fact 2026-07-08 Operating cash flow, capex, FCF, buybacks, dividends, SBC CASH_FLOW / latest annual
Company earnings releases via Alpha Vantage reported fact 2026-07-08 Reported EPS, surprise history EARNINGS / quarterly
Sell-side consensus via Alpha Vantage consensus estimate 2026-07-08 Forward revenue/EPS consensus, analyst count EARNINGS_ESTIMATES
Earnings calendar via Alpha Vantage market data 2026-07-08 Next earnings date, catalyst timing EARNINGS_CALENDAR
Company guidance company guidance 2026-07-08 FY guided revenue / non-GAAP EPS basis company guidance / earnings call
MCH segment model (from filings & disclosures) house estimate 2026-07-08 Segment revenue, margins, multiples, AI decomposition company_context (authored, tagged)
MCH qualitative analysis inference 2026-07-08 Moat, regulatory risk, scenario macro, catalysts company_context enrichment (authored)
MCH investment thesis & falsification triggers house estimate 2026-07-08 Thesis, anti-thesis, thesis-break signals authored §5.3

Citation coverage: 13/14 mandated claims sourced. Filing URLs are not available via the market-data provider; company statements are cited as 10-K/10-Q via Alpha Vantage.

Load-Bearing Assumptions

DCF: WACC 9%, terminal multiple 23×, FY+5 revenue $4B. Triangulation leans 41% on DCF, 29% on PWEV.

Reasons the Thesis Could Fail (Falsifiable)

Pre-registered signals that would break the thesis — each polices a specific scenario boundary and is checked at every earnings update:

  • Organic revenue growth (constant currency, ex-M&A) < 0.01 (2 consecutive prints → Industrial-PMI Recession / Inventory Reset). The base case rests on low-single-digit organic volume. Two quarters below 1% organic would place IDEX between the recession and base scenario drivers and confirm the short-cycle destock is not a one-quarter distortion.
  • Adjusted (non-GAAP) operating margin < 0.2 (2 consecutive prints → Industrial-PMI Recession / Inventory Reset). Base-case value depends on margin holding near the low-twenties. A sustained print below 20% signals decremental margins are running ahead of cost actions and moves the earnings path toward the recession driver of 18.5%.
  • Book-to-bill (orders / revenue) in short-cycle segments < 0.95 (2 consecutive prints → Industrial-PMI Recession / Inventory Reset). Book-to-bill leads revenue for short-cycle machinery. Two quarters below 0.95 would flag a forward volume shortfall against the base-case low-single-digit organic assumption before it appears in reported sales.
  • Trailing FCF conversion (FCF / adjusted net income) < 0.9 (2 consecutive prints → Structural — Portfolio / End-Market Disruption). IDEX's quality rests on high cash conversion funding bolt-on M&A and the dividend. A sustained conversion below 90% would indicate working-capital or capex leakage that undermines the capital-allocation engine central to the compounder thesis.
  • Goodwill and intangible impairment charge > 0.2 (single event → Structural — Portfolio / End-Market Disruption). A material impairment on an acquired platform (charge exceeding ~$0.20B, roughly a fifth of annual adjusted net income) would evidence a portfolio misstep and support the structural-impairment mechanism where earnings and the multiple de-rate together.

Fact / Inference / Speculation

  • FACT: Spot $221; 52-week range $155–$230; engine rating HOLD; base-case target $227 (+3%). (source: Alpha Vantage 2026-06-27, 8 July 2026)
  • INFERENCE: Triangulated FV $198 (-10% vs spot · triangulated FV); the rating tracks the Monte-Carlo + scenario-PWEV core; the cash-flow anchor sits below the multiple-discipline core.
  • SPECULATION: At current prices the embedded bet is that the market keeps paying the current multiple through the capex cycle — a regime call the engine cannot verify from fundamentals alone.

Recommendation: HOLD

Balanced: triangulated fair value $198 (-10% vs spot); the outcome hinges on P/E Multiple. The debate is P/E Multiple — fundamentally a multiple/regime call.

Disclosures & Limitations

This report is for informational and research purposes only. It is not personalised investment advice and does not consider any investor's objectives, financial situation, risk tolerance, tax position, or liquidity needs.

  • No suitability assessment has been performed for any individual.
  • Market data may be delayed or inaccurate; figures are as of the analysis date.
  • Model outputs (fair values, targets, scenario probabilities) are estimates and may be wrong.
  • Forecasts are uncertain; past performance is not indicative of future returns.
  • The author or publisher may hold positions in securities mentioned.
  • Users should verify information against primary sources (company filings) before acting.
  • Investing involves risk of loss; there is no guarantee any target price is achieved.
  • Ratings follow a defined research methodology (12-month expected-return thresholds), not individual circumstances.
Disclosures. This document is produced by MCH Advisory Services for informational and quantitative-research purposes only. It does not constitute investment, financial, legal or tax advice, nor an offer or solicitation to buy or sell any security. Price targets and probabilities are model outputs, not guarantees; past performance and backtested/simulated figures are not reliable indicators of future results. The author may hold positions in instruments mentioned and is not a registered financial adviser. Conduct your own due diligence and consult a qualified, registered adviser before making any investment decision.